tiprankstipranks
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
Company AnnouncementsArgenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
26d ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
PremiumCompany Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
2M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
PremiumCompany Announcements
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
2M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
PremiumCompany Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
2M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
PremiumCompany Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
3M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
PremiumCompany AnnouncementsArgenica Chair Steps Down as Biotech Prepares for Next Growth Phase
3M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
Premium
Company Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
4M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
Premium
Company Announcements
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
5M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
PremiumCompany Announcements
Argenica Therapeutics AGM Resolutions Passed Successfully
5M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
PremiumCompany Announcements
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
5M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
PremiumCompany Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
5M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
5M ago
AGN
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
PremiumCompany AnnouncementsArgenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
6M ago
AGN
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
Premium
Company Announcements
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
6M ago
AGN
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
Premium
Company Announcements
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
6M ago
AGN
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
PremiumCompany Announcements
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
7M ago
AGN
Argenica Therapeutics Sets Date for Annual General Meeting
PremiumCompany Announcements
Argenica Therapeutics Sets Date for Annual General Meeting
7M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
PremiumCompany Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
7M ago
AGN
Argenica Therapeutics Unveils Phase 2 Trial Results
PremiumCompany Announcements
Argenica Therapeutics Unveils Phase 2 Trial Results
7M ago
AGN
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
PremiumCompany AnnouncementsArgenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
7M ago
AGN
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
Premium
Company Announcements
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
7M ago
AGN
Argenica Therapeutics Releases 2025 Corporate Governance Statement
Premium
Company Announcements
Argenica Therapeutics Releases 2025 Corporate Governance Statement
8M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >